Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled TrialsMegan E. B. Clowse, Daniel J. Wallace, Richard Furie et al.|Arthritis & Rheumatology|2016Cited by 237
Genetic Interactions With <i>CLF1</i> Identify Additional Pre-mRNA Splicing Factors and a Link Between Activators of Yeast Vesicular Transport and SplicingKevin R. Vincent, Brian C. Rymond, Kathryn Hobbs et al.|Genetics|2003Cited by 48